Results

Total Results: 344 records

Showing results for "liver".
Users also searched for: hepatitis c

161. Outcome Definition and Measurement in Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/outcome-definition-and-measurement-chapter-6.pptx
     January 01, 2013 - more aggressive in subjects receiving one treatment than another (i.e., surveillance bias; e.g., when liver … testing is preferentially performed in patients using a new drug being compared to other treatments for a liver

162. Anabolic Steroids | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/anabolic-steroids

163. Disposition of Comments Report for Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
     July 10, 2012 - Peer Reviewer #4 Structured Abstract p. vii, ll. 32-35: Since mortality and alcohol-related liver … enzymes be included in alcohol-related liver problems? … No, liver enzyme levels are not included in alcohol-related liver abnormalities. … Liver enzyme abnormalities can indicate a number of different things and don’t necessarily reflect … ES14, l. 5: See above on “alcohol-related liver problems”.

164. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
     January 01, 2015 - mellitus, what is the comparative safety of the monotherapy FDA-approved diabetes medications regarding liver … comparative safety of metformin-based combinations of FDA-approved diabetes medications regarding liver … Nephropathy – Neuropathy • We included studies addressing the following safety outcomes for KQ3: – Liver … Other Outcomes The evidence on the outcomes of liver injury, pancreatitis, lactic acidosis, severe … with ketoacidosis had evidence of autoimmune diabetes.72 Evidence on other adverse events, including liver

165. Amended Protocol: Management of Infantile Epilepsy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
     March 07, 2021 - cognitive defect'/de OR 'developmental delay'/de OR 'developmental disorder'/de OR dystonia/de OR 'liver … neurodevelopment*) NEAR/3 (delay* OR disorder* OR regress*)) OR dystonia OR hypohidrosis OR hypohydrosis OR (liver

166. Disposition of Comments: Technical Brief No. 39_Disparities and Barriers to Pediatric Cancer Survivorship Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-39-pediatric-cancer-survivorship-comments.pdf
     March 01, 2021 - KI Reviewer #2 Background P1, L20-21: "liver disease" doesn't come up for me as a major organ toxicity … Thank you for pointing this out; we have removed liver disease from this list. … disease and heart failure, decreased pulmonary function, infertility, hormonal changes, kidney failure, liver

167. Ultrasound | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/ultrasound

168. Inhalants | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/inhalants

169. Vitamin E | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/vitamin-e

170. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
     April 01, 2010 - tumor types and stage IV disease: breast, colorectal, esophagus/stomach, genitourinary, head and neck, liver … 36 (30%) 9 (8%) Cancer Type Breast Colorectal Esophagus/stomach Genitourinary Head and neck Liver

171. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
     November 07, 2023 - Consider changing “liver cirrhosis” to “liver disease including cirrhosis” and “fetal alcohol syndrome … individual medication (for acamprosate, severe renal impairment, and for naltrexone, acute hepatitis, liver

172. Topic Brief: Interventions to Decrease Hospital Length of Stay (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-hospital-length-of-stay.pdf
     November 01, 2019 - Enhanced recovery after surgery program reduces length of hospital stay and complications in liver resection … review restricted studies to those that included four prespecified ERAS components.40 B-4 • Liver … One review focused on all liver surgeries except for transplantation42; and the other focused on liver

173. Organ Transplantation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/organ-transplantation

174. Calcineurin_Inhibitors_Protocol_FINAL_10-07-2014 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
     October 08, 2014 - Tacrolimus received FDA approval in 1994 for liver transplant recipients, and in 1997 for kidney transplants … Tacrolimus received approval in 1994 for use in liver transplants and in 1997 for use in kidney transplants … receiving different types of solid organ transplants (e.g., mixes renal transplant recipients and liver

175. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - mean age 54; 50% female; 20% black; 100% had CVD; 30% had diabetes) Exclusion criteria: chronic liver … disease, liver transaminase levels greater than normal; renal insufficiency (serum creatinine>2, … more than 2 portions of oily fish weekly or use of fish oil supplements; pain at rest; ulceration; liver … No changes were seen in liver, thyroid, or kidney function. No AEs reported. … international normalized ratio; KIM-1 Kidney Injury Molecule-1; LDL low density lipoprotein; LFABP liver-type

176. Digestive Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/digestive-diseases

177. Carbohydrates | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/carbohydrates

178. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
     January 01, 2012 - Infection Hepatitis C virus (HCV) is a major public health concern, the primary cause of death from liver … disease, and the leading cause for liver transplantation in the United States. … who are prior nonresponders to IFN/RBV with other comorbid conditions, such as nonalcoholic fatty liver … Effective treatment could also reduce the long-term costs of complications such as cirrhosis and liver … In: 61st Annual Meeting of the American Association for the Study of Liver Diseases; 2010 Oct 30-

179. Organisation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
     June 16, 2008 - Skeletal Radiology 2004;33(9):524-30. 15483754 Liver (Hepatocellular carcinoma) Ahmadi T, Itai … Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver … [Dose-volume histogram analysis of patients with hepatocellular carcinoma regarding changes in liver … Concurrent proton beam radiotherapy and systemic chemotherapy for the metastatic liver tumor of gastric … reporting outcome) Serious harms (excluding those attributed to co- interventions by authors) Liver

180. Cystic-Fibrosis-Hgh Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
     August 01, 2012 - Up-to-date Up-to-date Liver Transaminases: 2 single-arm trials found November 2011 No new evidence … Investigator Other Experts Conclusion from SCEPC Validity of CER conclusion(s) limited reporting of liver … 20114 1 male youth, age 16 years on insulin, antibiotics, and glucocorticoid therapy following liver … Quality/Applicabilit y Findings of S. aureus infection, allergic bronchopulmonary aspergillosis, liver … CF patients on rhGH rarely experienced a transient increase in liver transaminases in two single-arm